Poor Pulmonary Function is Not Associated with Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-institutional Analysis

Authors

M. Guckenberger, University Of Wuerzburg
J. Belderbos, NKI-AVL,Amsterdam
A. Hope, Princess Margaret Hospital TorontoFollow
L. L. Kestin, William Beaumont Hospital
M. Werner-Wasik, Thomas Jefferson University and HospitalsFollow
J. J. Sonke, NKI-AVL AmsterdamFollow
Y. Xiao, Thomas Jefferson University and HospitalsFollow
D. Yan, William Beaumont HospitalFollow
J. Wilbert, University Of Wuerzburg
I. S. Grills, William Beaumont Hospital

Abstract

Purpose/Objective(s): Stereotactic body radiotherapy (SBRT) is considered as the treatment of choice for stage I non-small cell lung cancer (NSCLC) in medically inoperable patients. It was the purpose of this study to evaluate whether pretreatment pulmonary function is predictive for survival and toxicity after SBRT.

American Society for Therapeutic Radiation Oncology (ASTRO) 52nd Annual Meeting October 31 - November 4, San Diego, CA

Recommended Citation

Guckenberger, M.; Belderbos, J.; Hope, A.; Kestin, L. L.; Werner-Wasik, M.; Sonke, J. J.; Xiao, Y.; Yan, D.; Wilbert, J.; and Grills, I. S. (2010) "Poor Pulmonary Function is Not Associated with Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-institutional Analysis," Bodine Journal: Vol. 3: Iss. 1, Article 33.
DOI: https://doi.org/10.29046/TBJ.003.1.032
Available at: https://jdc.jefferson.edu/bodinejournal/vol3/iss1/33